Board Meeting12 Aug 2026, 01:50 pm
Eiko Lifesciences Declares Un-Audited Financial Results for Q1 FY27
AI Summary
Eiko Lifesciences Ltd announced that its Board of Directors, in a meeting held on August 12, 2026, approved and took on record the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026. The results were accompanied by a Limited Review Report from the statutory auditors, PSV Jain & Associates. The company has complied with SEBI Listing Regulations and Indian Accounting Standards (Ind AS 34). The review confirmed no material misstatements in the financial statements.
Key Highlights
- Board approved un-audited standalone and consolidated financial results.
- Financial results are for the quarter ended June 30, 2026.
- Limited Review Report from statutory auditors is enclosed.
- Company complies with SEBI Listing Regulations and Ind AS 34.
- No material misstatements were found in the review.
Price Impact
More from EIKO